PER 34.1% 8.9¢ percheron therapeutics limited

James Garner CEO upbeat on prospects., page-5

  1. 529 Posts.
    lightbulb Created with Sketch. 340
    Reads like a horrible process for shareholders to get their money back from the NASDAQ, hence they sell cheap now on the ASX. Interesting point about trouble getting finance with a dual listing.... Something to remember.

    Hope we avoid getting caught up in red tape like that.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.